Pediatrix Medical Group, Inc. - 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Pediatrix Medical Group, Inc., covering the period ended September 30, 1998. The Company operates as a physician group practice specializing in pediatric care. During the first nine months of 1998, the Company aggressively expanded through the acquisition of thirteen physician group practices.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1998 | Nine Months Ended Sep 30, 1998 |
|---|---|---|
| Net Patient Service Revenue | $49.4 million | $133.3 million |
| Net Income | $7.6 million | $20.9 million |
| Net Income Per Share (Diluted) | $0.48 | $1.31 |
| Operating Margin | 26.5% | 26.2% |
| Net Margin | 15.5% | 15.6% |
| Cash and Cash Equivalents | $0.6 million | $0.6 million (Ending Balance) |
| Working Capital | $14.7 million | $14.7 million |
| Debt (Line of Credit) | $15.3 million | $15.3 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 43.3% for the quarter and 44.8% for the nine-month period compared to 1997. Approximately 83% to 90% of this growth is attributed to new units acquired, with same-unit revenue growth of 7.4% (quarter) and 5.5% (nine months).
- Expense Increases: Salaries and benefits rose 38.7% (quarter) and 39.2% (nine months), driven primarily by hiring new physicians to support acquisitions. Depreciation and amortization doubled (101.5% increase for nine months) due to goodwill amortization from acquisitions.
- Liquidity Shift: Cash and cash equivalents dropped significantly from $18.6 million at year-end 1997 to $0.6 million at September 30, 1998. This decrease was primarily due to $82.0 million in cash used for physician group acquisitions and investment purchases, partially offset by operating cash flow of $21.8 million and a new $15.3 million draw on the line of credit.
- Profitability: Net income increased 38.7% (quarter) and 43.1% (nine months). However, net income as a percentage of revenue decreased slightly (from 16.0% to 15.5% for the quarter) due to reduced investment income and increased interest expense from borrowings.
Guidance, Outlook, and Risks
- Capital Resources: Management anticipates that funds from operations and the remaining capacity under its $75 million credit facility will be sufficient to meet working capital and capital expenditure needs for the next twelve months.
- Year 2000 Compliance: The Company has reviewed its systems and believes modifications will prevent significant operational issues. However, risks remain if vendors or payors fail to make necessary conversions, which could materially adversely affect financial results.
- Legal Contingencies: The Company is involved in pending medical malpractice actions, which are generally covered by insurance. Management does not expect these to have a material impact on financial position.
- Acquisition Strategy: The Company continues to utilize a mix of cash and stock for acquisitions. Pro forma data suggests that if 1997 and 1998 acquisitions had occurred on January 1, 1997, net income would have been higher, though this is not indicative of future results.
Investor Verification Checklist
- Verify the sustainability of same-unit revenue growth (7.4% quarterly) versus the heavy reliance on acquisitions for total revenue growth.
- Monitor the utilization of the $75 million credit facility, as cash reserves have been depleted to fund acquisitions.
- Assess the impact of increased amortization expenses on future operating margins as the acquired goodwill is amortized over 25 years.
- Confirm the status of Year 2000 compliance for key payors and vendors to mitigate potential operational disruptions.
- Review the details of the 13 physician group acquisitions to understand the integration costs and revenue contribution of these new units.